Stephen J. Nicholls
Elsevier Health Sciences
e druk, 2018
9780323583480
Lipidology, An Issue of Cardiology Clinics
Specificaties
Gebonden, blz.
|
Engels
Elsevier Health Sciences |
e druk, 2018
ISBN13: 9780323583480
Rubricering
Onderdeel van serie
The Clinics: Internal Medicine
Levertijd ongeveer 8 werkdagen
Samenvatting
This issue of Cardiology Clinics, edited by Dr. Stephen Nicholls, focuses on Lipidology. Topics include, but are not limited to: Impact of lipoproteins on atherobiology; Lessons from genomic studies; Lipids and lipoproteins in risk prediction; Optimizing statins and ezetimibe in guideline focused management; Statin intolerance; Lipid lowering agents and diabetes risk; PCSK9 inhibitors; Bempedoic Acid; Triglyceride rich lipoproteins; Omega 3 Fatty Acids; Lipoprotein; CETP inhibitors; HDL infusions; and Targeting HDL functionality.
Specificaties
Inhoudsopgave
<p>Lipidology – Table of Contents</p> <p>Preface: Lipidology </p> <p>Impact of Lipoproteins on Atherobiology: Emerging Insights </p> <p>Causal Effect of Lipids and Lipoproteins on Atherosclerosis: Lessons from Genomic Studies</p> <p>Lipids and Lipoproteins in Risk Prediction</p> <p>Optimizing Statins and Ezetimibe in Guideline-Focused Management</p> <p>Statin Intolerance: Some Practical Hints </p> <p>Treating Dyslipidemia in Type 2 </p> <p>Proprotein Convertase Subtilisin Kexin 9 Inhibitors </p> <p>Bempedoic Acid (ETC-1002): A Current Review </p> <p>Triglyceride-Rich Lipoproteins</p> <p>Evolution of Omega-3 Fatty Acid Therapy and Current and Future Role in the Management of Dyslipidemia</p> <p>Is Lipoprotein(a) Ready for Prime-Time Use in the Clinic?</p> <p>Cholesteryl Ester Transfer Protein Inhibitors as Agents to Reduce Coronary Heart Disease Risk</p> <p>High-Density Lipoprotein Infusions</p> <p>High-Density Lipoproteins: Effects on Vascular Function and Role in the Immune Response</p> <p>Intravascular Ultrasound Studies of Plaque Progression and Regression: Impact of Lipid-Modifying Therapies</p>